SCHEMBL4780704

SCHEMBL4780704

Cc1cc(C(=O)OCl)ccc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.43
HDAC1 Q13547 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
NOTUM Q6P988 1/20 0.39
MAPT P10636 3/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
CASP3 P42574 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
PLA2G7 Q13093 1/20 0.37
RAB9A P51151 2/20 0.36
HSD17B1 P14061 1/20 0.36
HSD17B2 P37059 1/20 0.36
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL854583 0.83 NOTUM (0.54) NOTUMMAPTKMT2AMEN1CASP3
SCHEMBL27973172 0.82 KMT2A (0.50) CES2CES1MAPTKMT2AMEN1
SCHEMBL10437093 0.82 CES2 (0.59) CES2CES1MAOAMAOBKMT2A
SCHEMBL2175971 0.80 CA12 (0.59) PIM1HDAC1HDAC6MAOAMAPT
SCHEMBL4024106 0.79 HTR7 (0.46) PIM1HDAC1HDAC6CES2CES1
SCHEMBL193625 0.79 PIM1 (0.46) PIM1HDAC1HDAC6CES2CES1
SCHEMBL4355959 0.78 SMN1; SMN2 (0.53) PIM1HDAC1HDAC6CES2CES1
SCHEMBL5674062 0.78 MAPT (0.47) HDAC1MAOAMAPTKMT2ACASP3
SCHEMBL29113751 0.76 CA12 (0.42) MAOAMAPTKMT2AMEN1RAB9A
SCHEMBL1924482 0.76 PIM1 (0.47) PIM1HDAC1HDAC6CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008006044-A2 SUBSTITUTED ACID DERIVATIVES USEFUL AS ANTIDIABETIC AND ANTIOBESITY AGENTS AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 2008-01-10 WO disclosed